Followers | 247 |
Posts | 49942 |
Boards Moderated | 51 |
Alias Born | 08/29/2007 |
Tuesday, February 13, 2024 6:28:43 AM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent TYRA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 08:48:45 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 08:46:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:12:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:08:53 PM
- Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights • PR Newswire (US) • 05/09/2024 08:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/07/2024 08:34:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:29:02 PM
- Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors • PR Newswire (US) • 05/07/2024 08:05:00 PM
- Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights • PR Newswire (US) • 03/19/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:38:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:40:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:58:21 PM
- Tyra Biosciences to Present at Upcoming Investor Conferences • PR Newswire (US) • 02/27/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 02:00:08 AM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/13/2024 09:36:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/12/2024 09:46:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/10/2024 12:26:21 AM
- Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference • PR Newswire (US) • 02/07/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:23:04 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/06/2024 09:56:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 11:05:32 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/02/2024 10:04:35 PM
- Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing • PR Newswire (US) • 02/02/2024 01:00:00 PM
- Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia • PR Newswire (US) • 02/01/2024 10:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 10:24:53 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM